Proactive tobacco treatment for household smokers through pediatric care
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
This study is testing a new way to help household smokers quit tobacco by using support from pediatric care to see if it can improve their chances of success.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 3200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Children's Hospital of Philadelphia Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT06582693 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of the Refer2Quit intervention, which aims to increase tobacco treatment and quit rates among household smokers by leveraging a clinical decision support system within electronic health records. Participants will be recruited from outpatient primary care practices associated with the Children's Hospital of Philadelphia, and will be randomly assigned to either an intervention group receiving tailored tobacco treatment options or a control group. The study also seeks to understand the characteristics of household members and pediatric patients that influence the success of the intervention.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who are current combustible tobacco users and have a valid cell phone number.
Not a fit: Patients who are under 18 years of age or do not identify as current combustible tobacco users will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve smoking cessation rates among household smokers, benefiting both the smokers and their families.
How similar studies have performed: Other studies have shown success with similar population health approaches for tobacco cessation, indicating potential for effectiveness in this intervention.
Eligibility criteria
Show full inclusion / exclusion criteria
Adult Intervention Subject Inclusion Criteria * Males or females ages ≥18 years in age * Self-identify as a current combustible tobacco user * Have a valid cell phone number Child Intervention Subject Inclusion Criteria * Must be a CHOP patient Adult Intervention Subject Exclusion Criteria * \<18 years in age. * Indicates no combustible tobacco smoking Child Intervention Subject Exclusion Criteria * Not a CHOP patient Adult Control Subject Inclusion Criteria * Males or females ages ≥18 years in age * Self-identify as a current combustible tobacco user * Have a valid cell phone number Child Control Subject Inclusion Criteria * Must be a CHOP patient Adult Control Subject Exclusion Criteria * \<18 years in age. * Indicates no combustible tobacco smoking Child Control Subject Exclusion Criteria * Not a CHOP patient
Where this trial is running
Philadelphia, Pennsylvania
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Brian P Jenssen, MD, MSHP — Children's Hospital of Philadelphia
- Study coordinator: Brian P Jenssen, MD, MSHP
- Email: jenssenb@chop.edu
- Phone: 267-559-1566
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.